MCLEAN, Va., Feb. 07, 2017 -- Gladstone Capital Corporation (NASDAQ:GLAD) announces the following event:
| What: | Gladstone Capital Corporation's First Quarter Ended December 31, 2016 Earnings Call & Webcast | |
| When: | Thursday, February 9, 2017 @ 8:30 a.m. EST | |
| Where: | http://edge.media-server.com/m/p/z4m62hfq | |
| How: | By webcast -- Log on to the web at the address above | |
| By phone -- Please call (855) 465-0177 | ||
| Contact: | Gladstone Capital Corporation, +1-703-287-5893 | |
A conference call replay will be available after the call and will be accessible through March 9, 2017. To hear the replay, please dial (855) 859-2056 and use conference number 56270169.
If you are unable to participate during the live webcast, the call will be archived on the website, www.gladstonecapital.com. The event will be archived and available for replay on the Company’s website through April 9, 2017.
Gladstone Capital Corporation is a publicly traded business development company that invests in debt and equity securities, consisting primarily of secured first and second lien term loans to lower middle market businesses in the United States. Information on the business activities of Gladstone Capital and all the Gladstone funds can be found at www.gladstonecompanies.com.
For further information: Gladstone Capital Corporation, 703-287-5893


Italy Fines Apple €98.6 Million Over App Store Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



